Preventing harm from high-alert medications.

BACKGROUND One of the 12 interventions that the Institute for Healthcare Improvement (IHI) recommends for its 5 Million Lives Campaign is "Prevent Harm from High-Alert Medications . . . starting with a focus on anticoagulants, sedatives, narcotics, and insulin." EXECUTING SYSTEM-LEVEL CHANGES: Three essential elements are needed to execute system-level changes in an organization: will, ideas, and execution. Will is developed by examining the status quo in an organization and agreeing that it is no longer acceptable. Ideas-changes that will make the system safer-can be found in the literature and in the experience of other hospitals and are the basis for the recommended general interventions to reduce errors and harm associated with high-alert medications. Execution, the process of making those changes real, requires commitment from senior leaders and clinical leaders, along with the organizational capacity to improve. The steps in the medication system are so interrelated that a change in one area will affect others' ability to complete their work. In addition, senior leadership and clinical leadership must visibly support the effort, connecting the reduction in high-alert medication-related harm to the overall hospital goal of harm reduction is essential. CONCLUSION The campaign's goal is to achieve a 50% reduction in harm related to high-alert medications. Employing strategies such as standardization and simplification will provide the foundation for improved medication safety.

[1]  D. Pollock,et al.  National surveillance of emergency department visits for outpatient adverse drug events. , 2006, JAMA.

[2]  David C Classen,et al.  Improving medication safety: the measurement conundrum and where to start. , 2003, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[3]  F. Griffin,et al.  Miles to go: an introduction to the 5 Million Lives Campaign. , 2007, Joint Commission journal on quality and patient safety.

[4]  T. Brennan,et al.  The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. , 1991, The New England journal of medicine.

[5]  T W Nolan,et al.  service Topic collections Notes , 2022 .

[6]  P. Kanjanarat,et al.  Nature of preventable adverse drug events in hospitals: a literature review. , 2003, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[7]  Richard Segal,et al.  Identifying clinically significant preventable adverse drug events through a hospital's database of adverse drug reaction reports. , 2002, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[8]  R. Resar,et al.  Standardization as a mechanism to improve safety in health care. , 2004, Joint Commission journal on quality and safety.

[9]  S. Schroeder,et al.  How Many Hours Is Enough? An Old Profession Meets a New Generation , 2004, Annals of Internal Medicine.

[10]  D. Bates,et al.  Relationship between medication errors and adverse drug events , 1995, Journal of General Internal Medicine.

[11]  P. Aspden,et al.  Preventing Medication Errors , 2007 .

[12]  P. Barach,et al.  Clarifying Adverse Drug Events: A Clinician's Guide to Terminology, Documentation, and Reporting , 2004, Annals of Internal Medicine.

[13]  G. J. Langley,et al.  The improvement guide : a practical approach to enhancing organizational performance , 1996 .